Giulia Donzuso
PERSONAL INFORMATION
Donzuso
Giulia
ORCID: https://orcid.org/0000-0003-4925-694X; Scopus profile: 41561290700
Born 12/01/1986
Italian
• EDUCATION
06/12/2023: National Scientific Abilitation for Associate Professor (Settore Concorsuale 06/D6 - Neurologia)
2014-2019: Specialty in Neurology (full marks and honor), University of Catania.
April to September 2019: Resident and Research Fellow at the Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan (Director: Prof. Massimo Filippi, Tutor: Dr. Federica Agosta)
2011-2014: PhD in “Neurological and Rehabilitative Sciences”, XXVI Cicle, University of “Magna Graecia” of Catanzaro.
2004-2010: Medical Degree (full marks and honor), University of Catania.
• PREVIOUS POSITIONS
December 2021 – November 2022 – research fellow in the project “PO-FESR Sicilia 2011-2020, Azione 1.1.5 'IR3MA - Parkinson Cyclone in Life".
April 2020 – October 2021 neurologist – regional health plan project for management of PD patients Progetto Obiettivo PSN 2016 Linea Progettuale 5 – Azione 5.17 dal titolo: “Implementazione dei percorsi assistenziali e riabilitativi per la gestione integrata ospedale-territorio-continuità di cura a domicilio per le malattie di Parkinson mediante sviluppo di sistemi di teleassistenza per la Sicilia Orientale”.
• FELLOWSHIPS AND AWARDS
2014: Award “Arturo Reggio” in Clinical Neuroscience.
2019: Fellow of the European Board of Neurology.
2021: Award best poster “Progetto giovani e ricerca”.
2022: Member of EAN Scientific Panel of Neuroimaging.
2023: Member of EAN Coordinating Panel for Diversity, Equity and Inclusion
• REVIEWING AND EDITORIAL ACTIVITIES
Editorial Board Member for BMC Neuroscience
Academic Editor for PLOS ONE
Review Editor for Frontier in Aging Psychiatry.
Reviewer for Frontiers in Pharmacology, Journal of Neurology, Neurological Sciences
• MEMBERSHIPS OF SCIENTIFIC SOCIETIES
Member of Italian Society of Neurology (SIN);
Member of Italian Academy for the study of Parkinson's Disease and Movement Disorders (LIMPE DISMOV);
Member of European Academy of Neurology (EAN);
Member of the International Parkinson and Movement Disorder Society (MDS).
• MAJOR COLLABORATIONS
Prof. Massimo Filippi and Dr Federica Agosta, Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132 Milan, Italy;
Prof. Vladimir Kostic, Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Parkinson’s disease Cognitive Study (PACOS), University of Catania and University of Palermo.
• OTHER
Experience in clinical trials as sub investigator/study coordinator
- European multicenter retrospective-prospective cohort study to observe Safinamide safety profile and pattern of use in clinical practice during the first post-commercialization phase. Study Z7219N02.
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease (SPARK).
- A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations.
- A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure.
- A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
Scientific publications
- 46
Bibliometric parametres
- H-index: 16